Page last updated: 2024-08-23

razoxane and carvedilol

razoxane has been researched along with carvedilol in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altieri, P; Barisione, C; Barsotti, A; Brunelli, C; Fabbi, P; Garibaldi, S; Ghigliotti, G; Manca, V; Patrone, F; Spallarossa, P	1
Altieri, P; Ballestrero, A; Barisione, C; Barsotti, A; Brunelli, C; Fabbi, P; Garibaldi, S; Ghigliotti, G; Manca, V; Spallarossa, P	1
Franco, VI; Harake, D; Henkel, JM; Lipshultz, SE; Miller, TL	1

Reviews

1 review(s) available for razoxane and carvedilol

Article	Year
Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future cardiology, 2012, Volume: 8, Issue:4 Topics: Adiponectin; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Anthracyclines; Antibiotics, Antineoplastic; Antioxidants; Carbazoles; Cardiolipins; Cardiotonic Agents; Carvedilol; Doxorubicin; Erythropoietin; Heart; Heart Diseases; Humans; Lipid Peroxidation; Liposomes; Neoplasms; Piperazines; Propanolamines; Purines; Razoxane; Risk Factors; Sildenafil Citrate; Sulfones; Survivors; Ventricular Dysfunction, Left	2012

Article

Year

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management.

Future cardiology, 2012, Volume: 8, Issue:4

Topics: Adiponectin; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Anthracyclines; Antibiotics, Antineoplastic; Antioxidants; Carbazoles; Cardiolipins; Cardiotonic Agents; Carvedilol; Doxorubicin; Erythropoietin; Heart; Heart Diseases; Humans; Lipid Peroxidation; Liposomes; Neoplasms; Piperazines; Propanolamines; Purines; Razoxane; Risk Factors; Sildenafil Citrate; Sulfones; Survivors; Ventricular Dysfunction, Left

2012

Other Studies

2 other study(ies) available for razoxane and carvedilol

Article	Year
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis. Biochemical and biophysical research communications, 2005, Sep-16, Volume: 335, Issue:1 Topics: Acetylcysteine; Animals; Apoptosis; Atenolol; Carbazoles; Carvedilol; Cell Line; Doxorubicin; Flow Cytometry; Free Radicals; Hydrogen Peroxide; Myocytes, Cardiac; Propanolamines; Rats; Razoxane; Receptors, LDL; Receptors, Oxidized LDL; RNA, Messenger; Scavenger Receptors, Class E; Up-Regulation	2005
Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase. Cardiovascular research, 2006, Feb-15, Volume: 69, Issue:3 Topics: Anthracenes; Antibiotics, Antineoplastic; Antioxidants; Blotting, Western; Carbazoles; Carvedilol; Catecholamines; Cell Line; Doxorubicin; Enzyme Activation; Flavonoids; Humans; Imidazoles; Imidazolines; Janus Kinase 1; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Propanolamines; Protein-Tyrosine Kinases; Pyridines; Razoxane	2006

Article

Year

Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis.

Biochemical and biophysical research communications, 2005, Sep-16, Volume: 335, Issue:1

Topics: Acetylcysteine; Animals; Apoptosis; Atenolol; Carbazoles; Carvedilol; Cell Line; Doxorubicin; Flow Cytometry; Free Radicals; Hydrogen Peroxide; Myocytes, Cardiac; Propanolamines; Rats; Razoxane; Receptors, LDL; Receptors, Oxidized LDL; RNA, Messenger; Scavenger Receptors, Class E; Up-Regulation

2005

Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase.

Cardiovascular research, 2006, Feb-15, Volume: 69, Issue:3

Topics: Anthracenes; Antibiotics, Antineoplastic; Antioxidants; Blotting, Western; Carbazoles; Carvedilol; Catecholamines; Cell Line; Doxorubicin; Enzyme Activation; Flavonoids; Humans; Imidazoles; Imidazolines; Janus Kinase 1; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Propanolamines; Protein-Tyrosine Kinases; Pyridines; Razoxane

2006